ENGLISH
CBS2017
Previous Next
Home < 科学研究

搜索结果

数量：1763 条

排序

Refine search

Clinical and angiographic outcomes of coronary dissection after paclitaxel-coated balloon angioplasty for small vessel coronary artery disease

Original Research | By Funatsu A, Kobayashi T, Mizobuchi M et al.

The mechanism of how angiographic results following paclitaxel-coated balloon (PCB) treatment for small vessel disease affect patient outcome remains unknown. In the present study, we aimed to investigate the correlation between coronary dissection immediately after PCB angioplasty and midterm outcome. From March 2014 to March 2017, 171 consecutive patients with 228 native coronary artery lesions who received PCB ang...

Optical Coherence Tomography Predictors for Recurrent Restenosis After Paclitaxel-Coated Balloon Angioplasty for Drug-Eluting Stent Restenosis

Original Research | By Miura K, Tada T, Habara S et al.

BACKGROUND - Little is known of the relationship between optical coherence tomography (OCT) findings and recurrent restenosis after paclitaxel-coated balloon (PCB) angioplasty for drug-eluting stent in-stent restenosis (DES-ISR). To identify the predictors of recurrent restenosis after PCB angioplasty, we investigated quantitative and qualitative OCT findings during PCB angioplasty for DES-ISR. Methods and Results: In al...

A randomized trial of bifurcation stenting technique in chronic total occlusions percutaneous coronary intervention

Clinical Trial | By Baystrukov V, Kretov EI, Boukhris M et al.

BACKGROUND - The optimal strategy to treat bifurcation lesions (BFLs) in a percutaneous coronary intervention (PCI) for chronic total occlusions (CTOs) remains unknown. AIMS - We sought to assess whether T-provisional or mini-crush is appropriate for BFLs within CTO vessels. PATIENTS AND METHODS - From January 2011 to December 2013, patients who underwent successful CTO gu...

One Versus 2-stent Strategy for the Treatment of Bifurcation Lesions in the Context of a Coronary Chronic Total Occlusion: A Multicenter Registry

Original Research | By Baeza Garzón F, Pan Álvarez-Ossorio M, Romero Moreno MÁ et al.

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society

Guideline | By CT January, LS Wann, H Calkins et al.

Wearable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death A Systematic Review and Meta-Analysis

| By A Masri, AM Altibi, S Erqou et al.

OBJECTIVES - This study sought to synthesize the available evidence on the use of the wearable cardioverter-defibrillator (WCD). BACKGROUND - Observational WCD studies for the prevention of sudden cardiac death have provided conflicting data. The VEST (Vest Prevention of Early Sudden Death) trial was the first randomized controlled trial (RCT) showing no reduction in sudden cardiac death as compared to ...

Wearable Cardioverter-Defibrillator after Myocardial Infarction

Clinical Trial | By Olgin JE, Pletcher MJ, VEST Investigators et al.

BACKGROUND - Despite the high rate of sudden death after myocardial infarction among patients with a low ejection fraction, implantable cardioverter-defibrillators are contraindicated until 40 to 90 days after myocardial infarction. Whether a wearable cardioverter-defibrillator would reduce the incidence of sudden death during this high-risk period is unclear. METHODS - We randomly assigned (in a 2:1 ratio) patients w...

Association of All-Cause and Cardiovascular Mortality With High Levels of Physical Activity and Concurrent Coronary Artery Calcification

Original Research | By DeFina LF, Radford NB, Barlow CE et al.

IMPORTANCE - Few data are available to guide clinical recommendations for individuals with high levels of physical activity in the presence of clinically significant coronary artery calcification (CAC). OBJECTIVE - To assess the association among high levels of physical activity, prevalent CAC, and subsequent mortality risk. DESIGN, SETTING, AND PARTICIPANTS ...

Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association

Original Research | By Benjamin EJ, Muntner P, American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee.

Risk Stratification in PAH

Expert Opinion | By Karlee K Hoffman, MD; Sir Raymond L. Benza, MD, FACC; Manreet Kanwar, MBBS, FACC

Pulmonary arterial hypertension (PAH) is a chronic disease of the pulmonary vasculature characterized by progressive narrowing of the pulmonary arteries, which in turn leads to increased pulmonary vascular resistance, right heart failure, and death.1 There has been a significant improvement in the available medical therapeutic options in this field that have impacted the short-term survival and morbidity in these patients.2 However, the medi...

By Article Type

Original Research 785
Review Article 294
Clinical Case Study 28
Clinical Trial 415
Perspective 9
Guideline 50

By Year

2019 5
2018 4
0 1

By Journal

Rev Esp Cardiol (Engl Ed). 1
N Engl J Med. 1
JAMA Cardiol. 1
JACC: Clinical Electrophysiology 1
J Am Coll Cardiol. 1
Coron Artery Dis. 1
Circulation. 1
Circ J. 1
Cardiovasc Interv Ther. 1
Am J Cardiol. 1

Limit By

Title
Content
|<<... 70 71 72 73 74 75 76 ...>>|
↑BACK TO TOP

左主干暨冠状动脉分叉病变峰会

南京市心血管医院丨南京市第一医院丨南京医科大学

长乐路68号丨210006丨中国 · 南京

Copyright ⓒ CBSMD Nanjing China. All rights reserved.

关于境内代表注册有疑问请联系彭红娟、徐海梅老师

+86 - 139 138 954 77 丨 +86 - 139 147 368 46 丨 cbsnj@cbsmd.org

关于境外代表注册有疑问请联系林玲老师

+86 - 139 518 845 96 丨 cbsnj@cbsmd.org

关于学术征集有疑问请联系赵莹莹女士

+86 138 154 085 17 丨 sub@cbsmd.org